Comparison of frequency of low APGAR score in babies born to normotensive patients with and without hyperuricemia in a tertiary care hospital

  • Faryal Noman
  • Nusrat Noor
  • Rabiah Anwar
  • Rabiya Akbar
  • Khan Muhammad Yaqub Doctor
Keywords: Hyperuricemia, uric acid, APGAR score.


Objective: To compare the frequency of low APGAR scores in babies born to normotensive patients with asymptomatic hyperuricemia with those without hyperuricemia.
Study Design: Cohort Study.
Place and Duration: This study was conducted at the department of gynaecology/obstetrics, Liaquat National Hospital Karachi from January 2015 to January 2016.
Materials and Methods: The sample size was calculated by using version 2, an open-source calculator. The sample size was calculated to be 165 in each group, which made a total of 330 patients. Non-probability consecutive sampling was chosen as the sampling technique. All normotensive pregnant females with blood pressure of less than 130/90 between 18 to 40 years of age, with singleton pregnancy at 37 weeks and beyond were included in the study. Normotensive pregnant females with hyperuricemia were the exposed group while normotensive pregnant females with normal uric acid levels were the non-exposed group. The exclusion criteria included patients with multiple gestations, medical disorders like gout, chronic renal failure, APLS, Rheumatoid Arthritis, etc, on anti-hypertensives and smokers. Fetal outcomes were assessed in all patients after delivery and a comparison of outcomes was made between two groups.
Results: The study was designed to compare the frequencies of low APGAR scores in babies born to normotensive patients with asymptomatic hyperuricemia to those without hyperuricemia. The main outcome in group A i.e. exposed group was 29 babies with low APGAR score (<7) with 17.5% and in group B, which was non-exposed, 12 (7.57%) of babies had low APGAR score (<7). P-value came out to be 0.0010. The difference was statistically significant.
Conclusion: It is concluded that there is a significant difference between the frequency of low APGAR scores in babies born to normotensive patients with hyperuricemia to those without hyperuricemia.


Morris RK, Riley RD, Doug M, Deeks JJ, Kilby MD. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre eclampsia: systematic review and meta analysis. BMJ.2012;345:e4342.
De Oliveria EP, Burini RC: High Plasma uric acid concentration: causes and consequences. DiabetolMetabSyn 2012, 4:12 DOI:
Sautin YY, Johnson RJ: uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides, Nucleic acids 2008,27:608-619 doi: 10.1080/1527770802138558. PMID: 18600514; PMCID: PMC2895915
Tejal P, AsthaD, Relationship of serum uric acid level to maternal and perinatal outcome in patients with hypertensive disorders of pregnancy. Gugarat Med J. 2014; 17:7-11.
Hawkins AT, Roberts JM, Mangos GJ, Davis GK, Roberts LM, Brown MA, Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy. A retrospective cohort study. BJOG. 2012; 119:484-492 2011.03232.x
Parrish M, Griffin M, Morris R, Darlog M, Owens MY, Martin JM. Hyperuricemia facilitates the prediction of maternal and perinated adverse outcome in patients with severe / superimposed pre eclampsia. J Marten fetal neonatal med.2010; 23:1451-1455. 2010.500429.
Basu P, Som S, Chaudhuri N, Das H. contribution of the blood glucose level in perinatal asphyxia. Eur J Pediatr. 2009; 14:833-38.
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007-2008. Arthritis Rheum, 2011; 14:3136-41. 30520
Amini E, Sheikh M, Hantoushzadeh S, Shariat M, Abdollahi A, Kashanian M. maternal hyperuricemia in normotensive singleton pregnancy, a pre natal finding with continuous perinatal and postnatal effects, a prospective cohort study. BMC Pregnancy child birth. 2014; 14: 104
Chang FM, Chow SN, huang HC, Hsich FJ, Chen HY, Lee TY, etal. The placental transfer and concentration difference in maternal and neonatal serum uric acid at parturition; comparison of normal pregnancies and gestosis. Biol Res Pregnancy Perinatal. 1987; 14:35-39 @ article {8c9788c8822e456ba2999a37a713420f.
Bhaskar N, Kaur H, Qazi N. serum calcium, magnesium and uric acid in pre eclamptic and normal pregnancies in a tertiary case hospital: a comparative analysis. Indian J Maternal child health 2011; 1:1-7
Akahori Y, Mosuyama H, Hiramastu Y. The correlation of maternal uric acid concentration with small for gestational fetuses in normotensive pregnant women. Gynecolobstat invest 2012;73:162-167. DOI 10.1159/000332391.
Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in pre eclampsia. Placenta 2008; 29 Suppl A: S67-S72 doi: 10.1016/J. Placenta . 2007.11.001. Epub 2008 Feb 21.
Laughon SK, Cator J, Roberts JM; uric acid concentrations are associated with insulin resistance and birth weight in normotensive pregnant women Am J obstetGynecol 2009; 201:582.e 1-e6. Doi: 10.1016/j.ajog.2009.06.043
Meneses-Leon J, Denova – Gutierrez E, Castonon-Robles S, Granados – Garcia V, Talavera JO, Rivera-Paredez B, et al. Sveetened beverage consumption and the risk of hyperuricemia in Mexican adults; a cross sectional study. BMC Public Health 2014; May 12.14:445. Doi
Kim SY, Devera MA, Choi HK. Gout and mortality. ClinexpRheumatol. 2008 Sep-Oct.26 (58upple 51): S115-9. S115-9. PMID: 19026153
Bainbridge SA, Von Versen-Hoynck F, Roberts JM: Uric acid inhibits placental system an aminoacid uptake. Placenta 2009; 30:195-200 doi: 10.1016/j.placenta. 2008.10.015.
Daise TA, Tasnim S, Yasmin N, Ahsan AKM, Khanam W, Rahman M: Maternal hyperuricemia and brith outcome in normotensive singleton pregnancy: A prospective cohort study. JMSCR. 2018. Oct; 06: 952-57.
Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J kidney Dis. 2004 Oct. 44(4): 624-50 PMID: 15384015.
Yang T, Ding X, Wang YL, Zeng C, Wei J, Li H, et al. Association between high sensitivity c-reactive protein and hyperuricemia. Rheumatol Int. 2016 Feb 10. Doi: 10.1007/S00296-016-3429-Z
Kim SY, Guevara JP, Kim KM, et al. hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009 Jul 15. 61(7): 885-92.
How to Cite
Noman F, Noor N, Anwar R, Akbar R, Yaqub K. Comparison of frequency of low APGAR score in babies born to normotensive patients with and without hyperuricemia in a tertiary care hospital. JRMC [Internet]. 30Sep.2021 [cited 4Dec.2021];25(3):390-4. Available from: